Arcadia Biosciences, Inc. — Director's Dealing 2019

Aug 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-08-26

Reporting Person: Plavan Matthew T (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-26	Common Stock	A	1000	$8.33	Acquired	1000	Direct
2019-08-26	Common Stock	A	1000	$9.22	Acquired	2000	Direct
2019-08-27	Common Stock	A	1000	$9.32	Acquired	3000	Direct
2019-08-27	Common Stock	A	1000	$9.30	Acquired	4000	Direct
2019-08-27	Common Stock	A	1000	$8.95	Acquired	5000	Direct
2019-08-27	Common Stock	A	2000	$8.93	Acquired	7000	Direct
2019-08-28	Common Stock	A	1000	$6.88	Acquired	8000	Direct